Driving Innovation for Preparedness: Accelerating MCM Development
June 22, 2026
28ABCDE
Type: Engagement Day Session
This panel will examine how the U.S. government is advancing medical countermeasure innovation to address the evolving threat landscape. Panelists will discuss federal priorities for research and development, approaches to strengthening collaboration with industry, and considerations for accelerating the development of medical countermeasures and innovations to address emerging infectious diseases. The conversation will also explore how government and industry can better align capabilities, timelines, and expectations to support preparedness, while providing attendees with insight into opportunities for engagement.
Moderator
Speakers
Director for Acquisition and Systems Management (DASM)
Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND)
Capability Portfolio Manager – Medical Readiness and Response
Chemical, Biological, Radiological, and Nuclear Defense (ODASW(CBRND))
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}